Project VSV-EBOVAC – Vaccine Safety and immunogenicity signatures of human responses to VSV-ZEBOV
Basic data
Acronym:
VSV-EBOVAC
Title:
Vaccine Safety and immunogenicity signatures of human responses to VSV-ZEBOV
Duration:
01/03/2015 to 28/02/2018
Abstract / short description:
Acquire knowledge of the innate and adaptive immune responses elicited in humans by VSV-ZEBOV vaccination, with specific emphasis on transcriptomics and metabolomics signatures. For CERMEL: A twelve month follow up visit.
Involved staff
Managers
Faculty of Medicine
University of Tübingen
University of Tübingen
Local organizational units
Department VII, Tropical Medicine
Department of Internal Medicine
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Funders
Brüssel, Belgium